Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The Institute for Clinical and Economic Review (ICER) in 2025 noted that price reductions and long-term benefits have improved GLP-1 cost-effectiveness relative to older assumptions ( [70] ), yet insurers still face high absolute spend
The Skinny Shot adds MIC lipotropic compounds that support the metabolic processes involved in fat processing, liver health, and insulin signaling
And pricing is very affordable
Moreover, an oral GLP-1 and amylin co-agonist (amycretin) is also in early phase clinical trials (Table 1)
US$ 20.21
US$ 23.54
US$ 26.23
US$ 22.14
US$ 27.83
